Agios Pharmaceuticals (AGIO) EPS (Basic) (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted EPS (Basic) of -$2.51 for Q1 2026, down 34.88% on a QoQ basis from -$1.86 in Q4 2025, and down 29.58% year-over-year from -$3.57 in Q1 2025.
Agios Pharmaceuticals (AGIO) EPS (Basic) (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' EPS (Basic) history runs 14 years deep, the most recent figure standing at -$2.51 for Q1 2026.
- Quarterly EPS (Basic) fell 29.58% year-over-year to -$2.51 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.36 (down 176.28% YoY) and the FY2025 annual result came in at -$7.12, down 160.04% from the prior year.
- EPS (Basic) was -$2.51 for Q1 2026 at Agios Pharmaceuticals, down from -$1.86 in the prior quarter.
- Across five years, EPS (Basic) topped out at $16.65 in Q3 2024 and bottomed at -$2.51 in Q1 2026.
- A 4-year average of -$0.43 and a median of -$1.72 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 1117.27% — and 2025, when it plunged 110.69%.
- Agios Pharmaceuticals' EPS (Basic) stood at -$1.72 in 2023, then climbed by 1.44% to -$1.7 in 2024, then decreased by 9.68% to -$1.86 in 2025, then slumped by 34.88% to -$2.51 in 2026.
- Business Quant data shows AGIO's EPS (Basic) at -$2.51 in Q1 2026, -$1.86 in Q4 2025, and -$1.78 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -2.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.51 |
| Dec 31, 2025 | -1.86 |
| Sep 30, 2025 | -1.78 |
| Jun 30, 2025 | -2.28 |
| Mar 31, 2025 | -1.94 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | 16.65 |
| Jun 30, 2024 | -1.95 |
| Mar 31, 2024 | -1.72 |
| Dec 31, 2023 | -1.72 |
| Sep 30, 2023 | -1.64 |
| Jun 30, 2023 | -1.62 |
| Mar 31, 2023 | -1.57 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.06 |
| Mar 31, 2021 | 28.26 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | -0.29 |
| Jun 30, 2020 | -0.13 |